352 related articles for article (PubMed ID: 8104920)
1. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
2. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
3. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
4. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.
Berns EM; Klijn JG; van Staveren IL; Portengen H; Noordegraaf E; Foekens JA
Eur J Cancer; 1992; 28(2-3):697-700. PubMed ID: 1350457
[TBL] [Abstract][Full Text] [Related]
7. c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.
Schneider J; Jimenez E; Rodriguez F; del Tanago JG
Oncol Rep; 1998; 5(1):49-52. PubMed ID: 9458291
[TBL] [Abstract][Full Text] [Related]
8. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Ottestad L; Andersen TI; Nesland JM; Skrede M; Tveit KM; Nustad K; Børresen AL
Acta Oncol; 1993; 32(3):289-94. PubMed ID: 8100712
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of pituitary adenoma invasiveness: a review.
Suhardja A; Kovacs K; Rutka J
J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.
Bertheau P; Steinberg SM; Merino MJ
Hum Pathol; 1998 Apr; 29(4):323-9. PubMed ID: 9563780
[TBL] [Abstract][Full Text] [Related]
11. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
13. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
15. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
16. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.
Kobayashi S; Iwase H; Itoh Y; Fukuoka H; Yamashita H; Kuzushima T; Iwata H; Masaoka A; Kimura N
Jpn J Cancer Res; 1992 Aug; 83(8):859-65. PubMed ID: 1356959
[TBL] [Abstract][Full Text] [Related]
18. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
19. A paradigm for oncogene complementation in human breast cancer.
Roux-Dosseto M; Martin PM
Res Virol; 1989; 140(6):571-91. PubMed ID: 2694252
[TBL] [Abstract][Full Text] [Related]
20. Oncogenes and antioncogenes in human breast carcinoma.
Leslie KO; Howard P
Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
